JaLCDOI 10.18926/AMO/32044
フルテキストURL fulltext.pdf
著者 Kimura, Ikuro| Ohnoshi, Taisuke| Nakata, Yasunari| Takasugi, Kenta| Fujii, Masafumi| Hayashi, Kyoichi| Kataoka, Mikio| Sato, Masaharu| Nishihara, Ryuji|
抄録 <p>Clinical trials of immuno-chemotherapy were conducted on malignant lymphoma patients. Patients during the period from 1972 through 1977 were allocated to two groups retrospectively according to the mode of treatment, i.e., chemotherapy alone (historical control group, 35 patients) and chemotherapy with OK-432 (treated group, 15 patients). Comparisons were made of the two groups, which were homogeneous with regard to induction chemotherapy, maintenance chemotherapy, stage and histologic type of disease. The treated group had a higher remission rate, and a longer remission duration and survival than the control groups, especially in patients with Hodgkin's disease but the difference was not statistically significant owing to the limited number of cases.</p>
キーワード malignant lymphoma chemotherapy nonspecific immunotherapy OK-432
Amo Type Article
発行日 1979-12
出版物タイトル Acta Medica Okayama
33巻
6号
出版者 Okayama University Medical School
開始ページ 471
終了ページ 478
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 English
論文のバージョン publisher
査読 有り
PubMed ID 94239
NAID 120002311472